Catastrophic consequences of the enormous use of hydroxychloroquine during COVID era on liver and kidney of male albino rats: an in-vivo study

Tanushree Samanta; Sagarika Mukhopadhyay; Suman K. Khanra; Anup Jana

doi:10.18203/2319-2003.ijbcp20232461

Authors

Tanushree Samanta Department of Human Physiology, Raja Narendra Lal Khan Women’s College (Autonomous), Affiliated to Vidyasagar University, Paschim Medinipur, West Bengal, India
Sagarika Mukhopadhyay Department of Human Physiology, Raja Narendra Lal Khan Women’s College (Autonomous), Affiliated to Vidyasagar University, Paschim Medinipur, West Bengal, India
Suman K. Khanra Department of Human Physiology, Raja Narendra Lal Khan Women’s College (Autonomous), Affiliated to Vidyasagar University, Paschim Medinipur, West Bengal, India
Anup Jana Department of Human Physiology, Raja Narendra Lal Khan Women’s College (Autonomous), Affiliated to Vidyasagar University, Paschim Medinipur, West Bengal, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20232461

Keywords:

COVID, Hydroxychloroquine, Liver, Kidney, Histopathology

Abstract

Background: Hydroxychloroquine (HCQ) is mainly used for the treatment of malaria but during COVID trial, it was used against coronavirus though no history of the drug is known against SARS COV 2 or any other respiratory ailment. Many case studies showed the adverse effects on liver and kidney in many patients after the exposure of HCQ. The main aim of this study is to know the effect of HCQ drug on the liver and kidney of male albino rat at a range of human equivalent dose that was given during COVID period.

Methods: After institutional animal ethics committee (IAEC) approval, ten male albino rats were obtained and divided into two groups-control and treated. Treated groups receives HCQ through oral gavage for six days and then serum, tissue enzymes and total serum bilirubin were measured. Histopathological study was done from liver and kidney tissue. After that statistical analysis was done.

Results: We found significant increase in enzymes glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and alkaline phosphatase (ALP) in the HCQ-treated rats than in control and this signifies that there might be damages that occurred in liver and kidney. Increased level of bilirubin in HCQ-treated rats indicate hyperbilirubinemia and may be a sign of jaundice or any other hepatic disorder. From histopathological identification we also found liver and kidney tissues got damaged due to exposure of HCQ.

Conclusions: From this study, we can conclude that the exposure of this drug might have led to the impaired function of organs that could have potentiated their ill fate.

Metrics

Metrics Loading ...

References

Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malaria J. 2011;10(1):1-2.

Browning DJ. Hydroxychloroquine and chloroquine retinopathy. Springer. 2014.

Lei ZN, Wu ZX, Dong S, Yang DH, Zhang L, Ke Z, et al. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacol Therap. 2020;216:107672.

Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155-66.

Fan J, Zhang X, Liu J, Yang Y, Zheng N, Liu Q, et al. Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(12):3232-6.

Browning DJ. Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. Am J Ophthalmol. 2013;155(3):418-28.

Tett SE, Cutler DJ, Day RO. Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. J Pharm Sci. 1992;81(2):155-9.

Lei ZN, Wu ZX, Dong S, Yang DH, Zhang L, Ke Z, et al. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacol Therap. 2020;216:107672.

Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis. PLoS Med. 2021;18(7):e1003682.

Directorate General of Health Services. Clinical management protocol: COVID-19. Version 4. New Delhi: Ministry of Health and Family Welfare; 2020. Available at: https://www.mohfw.gov.in/pdf/Clinical ManagementProtocolforCOVID19dated27062020.pdf. Accessed on 14 March 2023.

CDC Guidelines. Guidelines for Treatment of Malaria in the United States. 2005. Available at: https://www.cdc.gov/. Accessed on 14 March 2023.

Mayo Foundation for Medical Education and Research (MFMER), Drugs and supplements, Hydroxychloroquine (oral route), 1998-2023. Available at: https://www.mayoclinic.org/drugs-supplements/hydroxychloroquine-oral-route/description/drg-20064216. Accessed on 14 March 2023.

Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Medecine et maladies infectieuses. 2020;50(4):384.

Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020;369.

Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020;35:101738.

Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, et al. A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19. Zhejiang da xue xue bao. J Zhejiang Univ Med Sci. 2020;49(2):215-9.

Khuroo MS. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. Int J Antimicrob Agents. 2020;56(3):106101.

Golden EB, Cho HY, Hofman FM, Louie SG, Schönthal AH, Chen TC. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus. 2015;38(3):E12.

Pereira BB. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review. J Toxicol Env Health Part B. 2020;23(4):177-81.

Gevers S, Kwa MS, Wijnans E, Van Nieuwkoop C. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clin Microbiol Infect. 2020;26(9):1276-7.

Falcão MB, de Goes Cavalcanti LP, Filgueiras Filho NM, de Brito CA. Case report: hepatotoxicity associated with the use of hydroxychloroquine in a patient with COVID-19. Am J Trop Med Hygiene. 2020;102(6):1214.

Reddy G. Kinetic Studies for the Release of Hydroxychloroquine Sulphate Drug (HCQ) In-vitro in Simulated Gastric and Intestinal Medium from Sodium Alginate and Lignosulphonic Acid Blends. Trends in Sciences. 2023;20(5):5318.

El Shishtawy MA, Hassan KH, Ramzy R, Berri F, Mortada M, Nasreddine S, et al. Comparative toxicity study of chloroquine and hydroxychloroquine on adult albino rats. Eur Sci J. 2015;1:399-407.

Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27.

Witter RF, Grubbs LM. An evaluation of the Reitman-Frankel method for the determination of serum glutamic oxalacetic transaminase. Clinica Chimica Acta. 1966;13(4):524-7.

Hansen PW. A simplification of Kind and King's method for determination of serum phosphatase. Scand J Clin Lab Investig. 1966;18(3):353-6.

Rutkowski RB, deBaare L. An ultramicro colorimetric method for determination of total and direct serum bilirubin. Clin Chem. 1966;12(7):432-8.

Parvin R, Pande SV, Venkitasubramanian TA. On the colorimetric biuret method of protein determination. Analytical Biochem. 1965;12(2):219-29.

Cheema B, Triplett D, Krishnamurthy P. 2306 Hydroxychloroquine-Induced Acute Liver Injury. Official J Am Coll Gastroenterol. 2019;114:S1286.

Sekar N, Kanthasamy A, William S, Subramanian S, Govindasamy S. Insulinic actions of vanadate in diabetic rats. Pharmacol Res. 1990;22(2):207-17.

Abdel Galil SM. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report. Lupus. 2015;24(6):638-40.

Hussain N, Chung E, Heyl JJ, Hussain B, Oh MC, Pinon C, et al. A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19. Cureus. 2020;12(8).

Singh H, Prakash A, Kalia AN, Majeed AB. Synergistic hepatoprotective potential of ethanolic extract of Solanum xanthocarpum and Juniperus communis against paracetamol and azithromycin induced liver injury in rats. J Trad Complement Med. 2016;6(4):370-6.

Younis NK, Zareef RO, Al Hassan SN, Bitar F, Eid AH, Arabi M. Hydroxychloroquine in COVID-19 patients: pros and cons. Front Pharmacol. 2020;11:597985.

Doyno C, Sobieraj DM, Baker WL. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol. 2021;59(1):12-23.

Chen X, Zhang Y, Zhu Z, Liu H, Guo H, Xiong C, et al. Protective effect of berberine on doxorubicin induced acute hepatorenal toxicity in rats. Mol Med Rep. 2016;13(5):3953-60.

Misra DP, Gasparyan AY, Zimba O. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int. 2020;40(11):1741-51.